This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Jiangsu Nhwa Pharmaceutical Co., Ltd, Shujing Biopharma Co., Ltd. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2026
Title: Xinjian Jiang: Innovator in Neuropsychiatric Medicaments
Introduction
Xinjian Jiang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neuropsychiatric diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Xinjian Jiang holds a patent for a "Heterocyclic substituted fused γ-carboline derivative, preparation method therefor, intermediate thereof and use thereof." This invention relates to a compound structure that can be utilized in the preparation of medicaments for treating neuropsychiatric diseases. The compound is represented by a specific formula, indicating its unique chemical structure and potential therapeutic applications.
Career Highlights
Throughout his career, Xinjian Jiang has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Shujing Biopharma Co., Ltd and Jiangsu Nhwa Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his development as an inventor and researcher in the field of biopharmaceuticals.
Collaborations
Xinjian Jiang has collaborated with several professionals in his field, including Zehong Wan and Jiaquan Feng. These collaborations have likely enriched his research and development efforts, fostering innovation and advancing the science behind neuropsychiatric treatments.
Conclusion
Xinjian Jiang's contributions to the field of medicinal chemistry, particularly through his patent on heterocyclic substituted fused γ-carboline derivatives, highlight his role as an innovator in the treatment of neuropsychiatric diseases. His work continues to pave the way for advancements in healthcare solutions.